Literature DB >> 9717684

State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

J E Hoppe1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9717684     DOI： 10.1007/bf02962373

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  43 in total

1.  Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections.

Authors:  S A Halperin; R Bortolussi; J M Langley; B Miller; B J Eastwood
Journal:  Pediatrics       Date:  1997-07       Impact factor: 7.124

2.  Interpretation of pharmacologic data in respiratory tract infections.

Authors:  E Bergogne-Bérézin
Journal:  Int J Antimicrob Agents       Date:  1993-11       Impact factor: 5.283

Review 3.  Antimicrobial susceptibility of Bordetella pertussis (Part I).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

4.  Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis.

Authors:  J E Hoppe; T Tschirner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

5.  Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin.

Authors:  Y Brun; F Forey; J P Gamondes; A Tebib; J Brune; J Fleurette
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

6.  In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative.

Authors:  M Asahara; A Tsuji; S Goto; K Masuda; A Kiuchi
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 7.  Quinolone arthropathy in animals versus children.

Authors:  J E Burkhardt; J N Walterspiel; U B Schaad
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

8.  In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.

Authors:  M Tsuji; Y Ishii; A Ohno; S Miyazaki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

9.  In vitro activity of flomoxef in comparison to other cephalosporins.

Authors:  C Simon; M Simon; C Plieth
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

10.  Prevention of secondary transmission of pertussis in households with early use of erythromycin.

Authors:  M A Sprauer; S L Cochi; E R Zell; R W Sutter; J R Mullen; S J Englender; P A Patriarca
Journal:  Am J Dis Child       Date:  1992-02
View more
  3 in total

Review 1.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Neurologic alterations in an HIV adult patient with pertussis: a case report.

Authors:  María Camila Arango-Granados; Iván Mauricio Trompa
Journal:  BMC Infect Dis       Date:  2020-07-02       Impact factor: 3.090

Review 3.  Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative.

Authors:  Ye Feng; Cheng-Hsun Chiu; Ulrich Heininger; Daniela Flavia Hozbor; Tina Quanbee Tan; Carl-Heinz Wirsing von König
Journal:  Lancet Reg Health West Pac       Date:  2021-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.